STAT signaling is one of the most well-characterized mode of PD-L1 induction in cancer cells [47–49], but IL-1β primarily signals though NFκB pathway [43], therefore, we were surprised to see an increase in p-STAT1 and p-STAT3 levels in HCC827 cells treated with IL-1β. This evidence concerns the gene STAT3 and cancer.